Hormone Therapy Doesn’t Improve Cognition in Post-Menopausal Women

Contraception
Contraception
The therapy did seem to improve symptoms of depression and anxiety in some women.

Menopausal hormone therapy (MHT) reportedly increases the risk of cognitive decline in women over age 65 y. It is unknown whether similar risks exist for recently postmenopausal women, and whether MHT affects mood in younger women. 

The ancillary Cognitive and Affective Study (KEEPS-Cog) of the Kronos Early Estrogen Prevention Study (KEEPS) examined the effects of up to 4 y of MHT on cognition and mood in recently postmenopausal women. KEEPS, a randomized, double-blinded, placebo-controlled clinical trial, was conducted at nine US academic centers.

READ FULL ARTICLE Curated publisher From journals.plos.org